Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2011-09-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2011-1677PMID 21956415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS.

  2011cited by this paper
• PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis.

  2011cited by this paper
• Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.

  2011influential reference
• Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986–2009

  2011cited by this paper
• Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.

  2011cited by this paper
• Stroke Incidence and Mortality Rates 1987 to 2006 Related to Secular Trends of Cardiovascular Risk Factors in Gothenburg, Sweden

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.

  2008cited by this paper
• Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.

  2008cited by this paper
• Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.

  2007cited by this paper
• Pathophysiology and types of dyslipidemia in PCOS.

  2007cited by this paper
• Endothelial and antithrombotic actions of HDL.

  2006cited by this paper
• The association between polycystic ovaries and endometrial cancer.

  2006cited by this paper
• Mortality and vascular outcomes in patients treated for thyroid dysfunction.

  2006cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004influential reference
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.

  2004cited by this paper
• Men at risk: occupation and male infertility.

  2004cited by this paper
• Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system

  2003cited by this paper
• Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.

  2003cited by this paper
• Cardiovascular morbidity and mortality associated with the metabolic syndrome.

  2001cited by this paper
• Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population.

  2001cited by this paper
• High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

  2001cited by this paper
• Cardiovascular disease in women with polycystic ovary syndrome at long‐term follow‐up: a retrospective cohort study

  2000influential reference
• Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women

  2000cited by this paper
• Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study

  2000cited by this paper
• Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

  1999cited by this paper
• Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group.

  1998cited by this paper
• Mortality of women with polycystic ovary syndrome at long-term follow-up.

  1998cited by this paper
• Risk factors for cardiovascular disease during the period 1985–1995 in Göteborg, Sweden. The GOT‐MONICA Project

  1997cited by this paper
• Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?

  1996cited by this paper
• Association between fibrinogen and other risk factors for cardiovascular disease in men and women. Results from the Göteborg MONICA survey 1985.

  1994cited by this paper
• Hemostatic and metabolic variables in women with polycystic ovary syndrome.

  1994cited by this paper
• Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome

  1992cited by this paper
• Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

  1992influential reference
• Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women

  1992cited by this paper
• Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men.

  1991cited by this paper
• Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

  1990cited by this paper
• Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

  1989cited by this paper
• Physical activity, physical fitness and risk of myocardial infarction.

  1976cited by this paper
• Physical Activity, Physical Fitness and Risk of Myocardial Infarction1

  1976cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957influential reference

• The preferred intervention characteristics and acceptability of intuitive eating as a lifestyle approach for polycystic ovary syndrome: A convergent mixed methods analysis

  2026cites this paper
• History of Infertility and Plasma Markers of Inflammation, Cholesterol, and Adipokines Among Participants in the Nurses’ Health Study II

  2026cites this paper
• Association of Polycystic Ovarian Syndrome with Endothelial Health, Cardiovascular Risk, and Cellular Aging.

  2025cites this paper
• Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: An updated meta-analysis of cohort studies

  2025cites this paper
• Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrom.

  2025cites this paper
• Polycystic ovarian syndrome and long-term risk of acute myocardial infarction and ischaemic stroke.

  2025cites this paper
• Polycystic Ovarian Morphology and Chronic Morbidity and Mortality in PCOS.

  2025cites this paper
• Associations of maternal per- and polyfluoroalkyl substance plasma concentrations during pregnancy with offspring polycystic ovary syndrome and related characteristics in Project Viva.

  2025cites this paper
• Association of Polycystic Ovary Syndrome with Clinical, Physical, and Reproductive Factors: A Data-Driven Analysis

  2025cites this paper
• Polycystic ovary syndrome with stroke, hypertension, and cardiovascular diseases: a systematic review and meta-analysis

  2025cites this paper
• Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease

  2024cites this paper
• Association between infertility and risk of cardiovascular diseases in young women

  2024cites this paper
• Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome

  2024cites this paper
• 2023 International Evidence‐Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta‐Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome

  2024cites this paper
• Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics

  2024cites this paper
• Economic Burden of Endometrial Cancer Associated With Polycystic Ovary Syndrome.

  2024cites this paper
• Combined Oral Contraceptives for Polycystic Ovary Syndrome: Pro and Contra (Review)

  2024cites this paper
• Evaluation of polycystic ovary syndrome pharmacotherapy.

  2024cites this paper
• Unmet clinical needs in women with polycystic ovary syndrome in regard to mental health: a cross-sectional study

  2024cites this paper
• Association of Hyperandrogenaemia With Hypertension and Cardiovascular Events in Pre-menopausal Women- A Prospective Population-Based Cohort Study.

  2024cites this paper
• Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update

  2024cites this paper
• Contemporary Management of the Patient with Polycystic Ovary Syndrome.

  2023cites this paper
• Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management.

  2023cites this paper
• A RECAPITULATION OF THE POLYCYSTIC OVARIAN DISORDER IN ADULT WOMEN AND THE RISK OF DISEASE ASSOCIATED WITH THE POLYCYSTIC OVARIAN DISORDER

  2023cites this paper
• Assessing and Addressing Social Determinants of Cardiovascular Health: JACC State-of-the-Art Review.

  2023cites this paper
• PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.

  2023cites this paper
• Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome

  2023cites this paper
• Cardiovascular Disease in Older Women

  2023cites this paper
• Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort

  2023cites this paper
• Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes

  2023cites this paper
• No difference in morbidity between perimenopausal women with PCOS with and without previous wedge resection.

  2023cites this paper
• Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome

  2023cites this paper
• The Association of Anti-Mullerian Hormone and Infertility Hormonal Imbalance with Polycystic Ovarian Syndrome Among Iraqi Patients.

  2023cites this paper
• Article Title: Young-onset diabetes in women with PCOS: a territory-wide retrospective analysis in Hong Kong.

  2023cites this paper
• Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria - a prospective population-based cohort study.

  2023cites this paper
• Association of polycystic ovary syndrome with cardiovascular disease among US female hospitalizations.

  2023cites this paper
• Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population

  2023cites this paper
• Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS)

  2023cites this paper
• Transcutaneous auricular vagus nerve stimulation as a potential novel treatment for polycystic ovary syndrome

  2023cites this paper
• Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome

  2022influential citation
• Effects of endocrine disorders on lipids and lipoproteins.

  2022cites this paper
• Incidental findings on coronary computed tomography in women with selected reproductive disorders

  2022cites this paper
• Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.

  2022cites this paper
• Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies

  2022cites this paper
• Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: A population‐based cohort study

  2022cites this paper
• Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

  2022cites this paper
• “I felt like she didn’t take me seriously”: a multi-methods study examining patient satisfaction and experiences with polycystic ovary syndrome (PCOS) in Canada

  2022cites this paper
• Consequences of hyperandrogenemia during pregnancy in female offspring: attenuated response to angiotensin II

  2022cites this paper
• Morbidity and mortality in PCOS: A prospective follow-up up to a mean age above 80 years.

  2022cites this paper
• Endothelial dysfunction in subfertile women with polycystic ovary syndrome.

  2022cites this paper
• Circulating Anti-Müllerian hormone in a cohort-study of women with severe obesity with and without polycystic ovary syndrome and the effect of a one-year weight loss intervention

  2022cites this paper
• Associations of endogenous androgens and sex hormone-binding globulin with kidney function and chronic kidney disease

  2022cites this paper
• Polycystic ovary syndrome and leukocyte telomere length: cross-sectional and longitudinal changes

  2022cites this paper
• Long-term health in women of age more than 40 years with polycystic ovary syndrome

  2022cites this paper
• Dyslipidemia in midlife women: Approach and considerations during the menopausal transition.

  2022cites this paper
• Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disorders

  2022cites this paper
• Polycystic Ovary Syndrome: Insights from Preclinical Research.

  2022cites this paper
• Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model.

  2022cites this paper
• Cardiometabolic biomarkers in women with polycystic ovary syndrome.

  2022cites this paper
• Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences.

  2021cites this paper
• Cardiovascular Disease in Older Women.

  2021cites this paper
• Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies

  2021cites this paper
• The impact of ageing and menopause in women with polycystic ovary syndrome

  2021influential citation
• Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study

  2021cites this paper
• An Update on Contraception in Polycystic Ovary Syndrome

  2021cites this paper
• Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.

  2021cites this paper
• Ovariectomy Improves Metabolic and Oxidative Stress Marker Disruption in Androgenized Rats: Possible Approach to Postmenopausal Polycystic Ovary Syndrome

  2021cites this paper
• Cardiometabolic Risk in Polycystic Ovary Syndrome: Current Guidelines.

  2021influential citation
• Natural history of polycystic ovary syndrome: A systematic review of cardiometabolic outcomes from longitudinal cohort studies

  2021cites this paper
• Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome

  2021cites this paper
• Polycystic Ovarian Syndrome and Menopause in Forty Plus Women

  2021influential citation
• Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study.

  2021cites this paper
• Polycystic Ovary Syndrome (PCOS) Transition at Menopause

  2021cites this paper
• An overview of polycystic ovary syndrome in aging women

  2021influential citation
• Pregnancy Protects Hyperandrogenemic Female Rats From Postmenopausal Hypertension

  2020cites this paper
• Cardiac function and tolerance to ischemia/reperfusion injury in a rat model of polycystic ovary syndrome during the postmenopausal period.

  2020cites this paper
• Polycystic ovary syndrome and aging: Health implications after menopause.

  2020cites this paper
• Characteristics of polycystic ovary syndrome throughout life

  2020cites this paper
• The Polycystic Ovary Syndrome (PCOS)

  2020cites this paper
• Aging women with polycystic ovary syndrome: menstrual cycles, metabolic health, and health-related quality of life

  2020cites this paper
• Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.

  2020cites this paper
• Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression

  2020cites this paper
• Longitudinal changes over three years in sex steroid hormone levels in women aged 70 years and over

  2020cites this paper
• Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution

  2020cites this paper
• Midlife women’s health consequences associated with polycystic ovary syndrome

  2020cites this paper
• Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study

  2020cites this paper
• Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis

  2020influential citation
• Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies

  2020cites this paper
• Reproductive hormones and anthropometry: a follow-up of PCOS and controls from perimenopause to above 80 years of age.

  2020cites this paper
• Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis

  2020influential citation
• Cardiovascular health and menopause in aging women with polycystic ovary syndrome

  2020cites this paper
• Gender differences in cardiovascular disease

  2019cites this paper
• Metabolic syndrome during menopause.

  2019cites this paper
• Kombinierte orale hormonale Kontrazeptiva (KOK): zwischen Nutzen und Risikobewertung-Ethinylestradiol (EE)/Chlormadinonacetat (CMA) und Thromboserisiko

  2019influential citation
• Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS.

  2019cites this paper
• 25 historic papers: an ASRM 75th birthday gift from Fertility and Sterility.

  2019cites this paper
• The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome

  2019cites this paper
• The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects

  2019cites this paper
• N1-methylnicotinamide as a possible modulator of cardiovascular risk markers in polycystic ovary syndrome.

  2019cites this paper
• Blood pressure in postmenopausal women with a history of polycystic ovary syndrome

  2019cites this paper